Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03789526

Enrollment

Registered

2018-12-28

Start date

2018-12-11

Completion date

2019-02-01

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound Guided Injection

Keywords

Tenosynovitis, ultrasound, diabetes mellitus

Brief summary

Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the management of tenosynovitis in DM patients.

Detailed description

The current study will based on follow up study, conducted among patients presenting at outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness grade 3. All patients will randomized in two groups: Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance. The affected tendons will scanned and scored for inflammation using ultrasound in all patients before the triamcinolone injection and then to be reassessed one month after the injection to determine the change in the tendons in both groups.

Interventions

PROCEDUREultrasound guidance

ultrasound guidance of tendon injection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

* Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. * Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* • Diabetes mellitus. * Disease duration 3 years or more. * Tenosynovitis of hand tendons with Richie tenderness grade 3.

Exclusion criteria

* • Patients with recent hand trauma. * Patients with inflammatory hand arthritis. * Previous tendon surgery. * Previous tendon injection. * Patients with contraindication for injection as related infection, uncontrolled DM or bleeding tendency.

Design outcomes

Primary

Measure	Time frame	Description
change in Tenosynovitis pain	one month	changes in VAS scale for pain,
change in Tenosynovitis tenderness	one month	changes in Richie index for tenderness.
changes in ultrasound images of the Tenoasynovitis.	one month	changes in Gery scale images, and power Doppler images of the tendons

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026